Fcγ receptor predictive genomic testing and the treatment of indolent non-Hodgkin lymphoma

Clin Lymphoma Myeloma Leuk. 2010 Oct;10(5):321-2. doi: 10.3816/CLML.2010.n.063.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Antineoplastic Agents / therapeutic use
  • Humans
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Lymphoma, Non-Hodgkin / genetics*
  • Lymphoma, Non-Hodgkin / pathology
  • Polymorphism, Genetic
  • Receptors, IgG / genetics*
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Receptors, IgG
  • Rituximab